Massive sequencing study links rare DNA alterations to type 2 diabetes
Scientists in the Radcliffe Department of Medicine (RDM) have identified new genetic targets for disease research and potentially drug development. An international consortium of scientists, including RDM researchers, has analyzed protein-coding genes from nearly 46,000 people, linking rare DNA alterations to type 2 diabetes. The study, one of the largest known of its type, includes […]
